2022 annual financial data
Dogwood Therapeutics 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -12,315,309 USD and net income was -12,247,834 USD.
Operating cash flow was -11,467,797 USD.
Get free Dogwood Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,315,309 USD
- Net income
- -12,247,834 USD
- Operating cash flow
- -11,467,797 USD